BSIM is a biotech company focused on the design of organ-targeted, high-quality drug candidates for the treatment of transthyretin-mediated amyloidoses.

ID: 1175096006616264706

linkhttps://www.bsimtx.com calendar_today20-09-2019 17:16:11